Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Noble

Showing results (541-550 of 568) with videos related to

Pageof 57
Sort By:
Evidence Report/Technology Assessment|January 16, 2014
Making health care safer II: an updated critical analysis of the evidence for patient safety practicesP G Shekelle, R M Wachter, P J Pronovost, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer NetworkOlivia Wagemann, Yan Li, Jason Hassenstab, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Brain : a Journal of Neurology|March 22, 2019
Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's diseaseJonathan Vöglein, Katrina Paumier, Mathias Jucker, et al.
European Journal of Medicinal Chemistry|June 19, 2019
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4Stephanie M Myers, Duncan C Miller, Lauren Molyneux, et al.
Pageof 57

Showing results (541-550 of 568) with videos related to

Sort By:
Pageof 57
Evidence Report/Technology Assessment|January 16, 2014
Making health care safer II: an updated critical analysis of the evidence for patient safety practicesP G Shekelle, R M Wachter, P J Pronovost, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer NetworkOlivia Wagemann, Yan Li, Jason Hassenstab, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Brain : a Journal of Neurology|March 22, 2019
Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's diseaseJonathan Vöglein, Katrina Paumier, Mathias Jucker, et al.
European Journal of Medicinal Chemistry|June 19, 2019
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4Stephanie M Myers, Duncan C Miller, Lauren Molyneux, et al.
Pageof 57